Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Sanofi ADS SNY Stock Portfolio Allocation Insight Q1 2026 Below Expectations TMDX TransMedics Group Q1 2026 earnings miss by 52 percent shares dip 15 percent Cemex CX Stock Is It Worth Your Money Cemex posts 676 EPS beat topping Street estimates Edgewise Therapeutics EWTX Stock 13F Filings Flatline 20260420 Where is Texas TCBS stock heading next Weakens 20260420 Is Insight Enterprises NSIT stock recovering momentum Q4 2025 EPS Exceeds Expectations State Street Technology Select Sector SPDR ETF XLK 20 April Rally Coincides with Rare SP 500 DoubleDigit Gain Historical Signals Point to Bullish LongTerm Outlook Should investors consider Abacus Global ABX stock right now Q4 2025 Earnings Beat Estimates EVC Entravision shares rise 080 percent following Q4 2025 earnings with no available consensus estimates Old Second OSBC Gains 191 Support Holds at 1978 20260518 Progress PRGS Reports Strong Q1 2026 Revenue NA EPS Beats Trumps Policies and Iran Conflict Complicate Kevin Warshs Federal Reserve Agenda Raising Questions for the Bull Market China Auto Executives Embrace Livestreaming to Engage Consumers Directly Sarepta SRPT Crushes Q1 2026 Estimates EPS 288 Tops Views Liberty LBRDK Q3 2025 Earnings 177 EPS Surges Past 127 Estimates Fuel Tech FTEK Drops 203 Key Support at 138 20260520 Jaguar Health JAGX Stock Jumps 283 Approaching 362 20260520 PGY Q1 2026 Earnings Massive EPS Beat of 263 Surprises Market Stock Declines Slightly BRX Q1 2026 Earnings Strong EPS Surprise of 635 Despite Slight Stock Decline SDST Q1 2026 Earnings WiderthanExpected Loss Weighs on Shares SRBK Q3 2025 Earnings Positive EPS Signals Improved Profitability HBIO Q1 2026 Earnings NarrowerThanExpected Loss Boosts Shares by 176 Novagold Resources NG Climbs 737 as Gold Sector Momentum Strengthens Ironwood Pharmaceuticals IRWD Slides 49 as Support Levels Tested Near 352 Park Hotels Resorts PK Climbs 1 as It Approaches Key Resistance Level Gilead Sciences GILD Edges Higher Modestly as Shares Hold Above Key Support